Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes.

Podobne zapisy

• Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.
  od: Pankuch, G A, i wsp.
  Wydane: (1993)
• In vitro activity of the new fluoroquinolone CP-99,219.
  od: Neu, H C, i wsp.
  Wydane: (1994)
• Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219).
  od: Wise, R, i wsp.
  Wydane: (1996)
• Dose-ranging study of CP-99,219 (trovafloxacin) for treatment of uncomplicated gonorrhea.
  od: Hook, E W, i wsp.
  Wydane: (1996)
• In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone.
  od: Gooding, B B, i wsp.
  Wydane: (1993)